<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04625491</url>
  </required_header>
  <id_info>
    <org_study_id>2020-4-2-HUVA</org_study_id>
    <nct_id>NCT04625491</nct_id>
  </id_info>
  <brief_title>Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.</brief_title>
  <official_title>Lower Limb Cutaneous Melanoma: Observational Prognostic Study About Specific Location of the Primary Lesion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Virgen de la Arrixaca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Virgen de la Arrixaca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study to know the relevance of specific anatomical location of cutaneous&#xD;
      melanoma on lower limbs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ambispective (retrospective and prospective) observational register of patients with&#xD;
      cutaneous melanoma on lower limbs are grouped in 1) proximal (thigh), 2) medium (leg), and 3)&#xD;
      distal (ankle and foot) location. Analysis of melanoma-specific overall and disease-free&#xD;
      survival will be made, as well as multivariant analysis for prognostic variables including&#xD;
      anatomical location.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2000</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Melanoma-specific overall survival</measure>
    <time_frame>Ten years</time_frame>
    <description>Melanoma-specific overall survival</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Melanoma-specific disease-free survival</measure>
    <time_frame>Ten years</time_frame>
    <description>Melanoma-specific disease-free survival</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cutaneous Melanoma</condition>
  <condition>Anatomical Pathological Condition</condition>
  <arm_group>
    <arm_group_label>Location on lower limb</arm_group_label>
    <description>Proximal (thigh) Medium (leg) Distal (ankle and foot)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Observational</description>
    <arm_group_label>Location on lower limb</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that were cared of cutaneous melanoma on the lower limb.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cutaneous melanoma on the lower limb&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Incomplete staging&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Pi単ero-Madrona, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor of Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Pi単ero-Madrona, MD PhD</last_name>
    <phone>+34 968369500</phone>
    <phone_ext>9677</phone_ext>
    <email>pineromadrona@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario &quot;Virgen de la Arrixaca&quot;</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Pi単ero, MD PhD</last_name>
      <email>antonio.pinero@carm.es</email>
    </contact>
    <investigator>
      <last_name>Antonio Pi単ero, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 6, 2020</study_first_submitted>
  <study_first_submitted_qc>November 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2020</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Virgen de la Arrixaca</investigator_affiliation>
    <investigator_full_name>Antonio Pinero-Madrona</investigator_full_name>
    <investigator_title>Specialist in Surgery, MD PhD</investigator_title>
  </responsible_party>
  <keyword>cutaneous melanoma</keyword>
  <keyword>lower limb</keyword>
  <keyword>prognostic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
    <mesh_term>Skin Neoplasms</mesh_term>
    <mesh_term>Pathological Conditions, Anatomical</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>An interim analysis of data is planned in 2020.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

